Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Con Call held on 12th February 202117-02-2021
17-02-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation of unaudited financial results for the period ended 31st December 2020.12-02-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Conference Call11-02-2021
Nath Bio-Genes (India) Ltd - 537291 - Financial Results For The Quarter And Nine Months Ended 31St December 2020
Financial Results for the quarter and nine months ended 31st December 202010-02-2021
Nath Bio-Genes (India) Ltd - 537291 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter End 31St December 2020.
Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2021 ,inter alia, to consider and approve unaudited financial results for the quarter end 31st December 2020.03-02-2021
Nath Bio-Genes (India) Ltd - 537291 - Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015.
Intimation of Retirement of Mr. Madhav Dhande (Marketing Lead)29-01-2021
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended December 31, 2020
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here21-01-2021
Nath Bio-Genes (India) Ltd - 537291 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of SEBI (DP) Regulation,201813-01-2021